RNA-peptide fusions for the in vitro selection of peptides and proteins

R W Roberts1, J W Szostak

  • 1Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.

Insights

Researchers created novel covalent RNA-peptide fusions using synthetic messenger RNAs (mRNAs) with puromycin. This technique enables the enrichment of specific mRNAs from complex mixtures, advancing in vitro protein evolution.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Synthetic Biology

Background:

  • Covalent fusion of messenger RNA (mRNA) and its encoded peptide or protein is a novel approach.
  • Synthetic mRNAs can be modified to incorporate puromycin, a peptidyl acceptor antibiotic, at their 3' end.

Purpose of the Study:

  • To generate and utilize covalent mRNA-peptide fusions for specific mRNA enrichment.
  • To explore the potential of these fusions in in vitro selection and directed protein evolution.

Main Methods:

  • In vitro translation of synthetic mRNAs carrying puromycin at the 3' end.
  • Generation of stable, covalent linkages between mRNA and encoded peptides.
  • Enrichment of specific mRNA-peptide fusions from complex mixtures using immunoprecipitation.

Main Results:

  • Successful generation of covalent mRNA-peptide fusions.
  • Demonstrated enrichment of synthetic mRNA-myc epitope peptide fusions from a pool of random sequences via immunoprecipitation.
  • Established the principle of selecting mRNA based on peptide properties.

Conclusions:

  • Covalent RNA-peptide fusions offer a new method for mRNA enrichment based on encoded peptide characteristics.
  • This approach provides an additional avenue for in vitro selection and directed evolution of proteins.
  • The technique has broad implications for protein engineering and synthetic biology.